Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jun 2026 for Aclaris Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleAnand Mehra
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-38.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Anand Mehra: trading record in brief
Anand Mehra is a declared insider of Aclaris Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). Between 3 June 2022 and 5 June 2026, the trades on record add up to 6 filings.
No open-market sale appears; the market trades are 1 purchase worth €1.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 option exercises.
The latest filing, published on 8 June 2026, reports an option exercise in Aclaris Therapeutics, Inc. The clock since the last published purchase (20 November 2024) now reads 697 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anand Mehra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
11,580 sharesCommon StockSEC:0001590102-26-000002:0
4,793 sharesCommon StockSEC:0001415889-25-016250:0
666,666 shares@ US$2.25100.0% of flowCommon StockSEC:0001415889-24-027348:0
Canonical exit: 17 Feb 2025 (T+90)
4,660 sharesCommon StockSEC:0001415889-24-015362:0
4,507 sharesCommon StockSEC:0001209191-23-034383:0
3,356 sharesCommon StockSEC:0001209191-22-034589:0
6 of 6 declarations
